journal article·2013-12-01Open access

Cast adhesive polyelectrolyte complex particle films of unmodified or maltose-modified poly(ethyleneimine) and cellulose sulphate: fabrication, film stability and retarded release of zoledronate

Bernhard Torger, David Vehlow, Birgit Urban, Samaa Salem, Dietmar Appelhans, Martin Müller

Biointerphases· Volume 8· Issue 1

Abstract

The bone therapeutic drug zoledronate (ZOL) was loaded at and released by polyelectrolyte complex (PEC) particle films composed of either pure poly(ethyleneimine) (PEI) or maltose-modified poly(ethyleneimine) (PEI-M) and oppositely charged cellulose sulfate attached to model germanium (Ge) substrates by solution casting. Dispersions of colloidally stable polyelectrolyte complex (PEC) particles in the size range 11–141 nm were obtained by mixing PEI or PEI-M, CS and ZOL in defined stoichiometric ratios. TRANS-FTIR spectroscopy was used to determine the stability of the PEC films against detachment, in-situ-ATR-FTIR spectroscopy for the ZOL loss in the PEC film and UV–VIS spectroscopy for the ZOL enrichment of the release medium. Films of casted ZOL/CS/PEI-M or ZOL/CS/PEI particles were stable in contact to water, while films of the pure drug (ZOL) and of the binary systems ZOL/PEI-M or ZOL/PEI were not stable against detachment. Retarded releases of ZOL from various PEC films compared to the pure drug film were observed. The molecular weight of PEI showed a considerable effect on the initial burst (IB) of ZOL. No significant effect of the maltose modification of PEI-25 K on IB could be found. Generally, after one day the ZOL release process was finished for all measured ZOL/PEC samples and residual amounts of 0-30% were obtained. Surface adhesive drug loaded PEC particles are promising drug delivery systems to supply and release a defined amount of bone therapeutics and to functionalize bone substitution materials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone health and treatments · Polymer Surface Interaction Studies · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Leibniz Institute of Polymer Research (IPF) Dresden 1 , Hohe Straße 6, Dresden, D-01069, Germany

References (31)

Show source-provided references
1. Transplantable delivery systems for in situ controlled release of bisphosphonate in orthopedic therapy10.1517/17425247.2011.541438 ↗
2. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs10.1073/pnas.0601643103 ↗
3. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration10.1016/j.bone.2004.10.004 ↗
4. Sol–gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia10.1002/jbm.a.32708 ↗
5. Bisphosphonate-laden acrylic bone cement: Mechanical properties, elution performance, and in vivo activity10.1002/jbm.b.31130 ↗
6. Bisphosphonate based coatings for hard tissue implants
7. Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats10.1080/17453670810016768 ↗
8. Release of pamidronate from poly(ethyleneimine)/cellulose sulphate complex nanoparticle films: An in-situ ATR-FTIR study10.1016/j.jpba.2012.03.047 ↗
9. 2013
10. Polycation cytotoxicity: a delicate matter for nucleic acid therapy-focus on polyethylenimine10.1039/c000190b ↗
11. Hyperbranched PEI with various oligosaccharide architectures: Synthesis, characterization, ATP complexation and cellular uptake10.1021/bm801310d ↗
12. Tailoring uptake and release of ATP by hybrid hydrogel composed by dendritic glycopolymer and PNIPAAm: First approaches towards multicompartment release systems10.1039/c1nj20455f ↗
13. Maltose- and maltotriose-modified hyperbranched poly(ethyleneimine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes10.1016/j.jconrel.2010.10.008 ↗
14. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis10.1056/NEJMoa067312 ↗
15. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: A phase III, double-blind, comparative trial
16. Prevalence, risk factors and clinical characteristics of osteonecrosis of the jaw (ONJ) in osteoporosis patients treated with bisphosphonates10.1016/j.clinthera.2007.08.008 ↗
17. The kidney and bisphosphonates10.1016/j.bone.2010.12.024 ↗
18. Preparation of monomodal polyelectrolyte complex nanoparticles of PDADMAC/poly(maleic acid-alt-α-methylstyrene) by consecutive centrifugation10.1021/la050716d ↗
19. Lindon · 2000
20. 1981
21. in-situ-ATR-FTIR and AFM studies on the influence of adsorption time on deposition and nanostructure of poly(ethyleneimine)/poly(acrylic acid) multilayers10.1002/masy.200850509 ↗
22. Polyelectrolyte complexes -Recent developments and open problems10.1016/0079-6700(89)90018-X ↗
23. Growth of polyelectrolyte complex nanoparticles: Computer simulations and experiments10.1021/jp800581y ↗
24. On particle coalescence in latex films (II)10.1007/BF01411504 ↗
25. Polymer diffusion across interfaces in latex films10.1021/j100113a008 ↗
26. Monomodal polyelectrolyte complex nanoparticles of PDADMAC/poly(styrenesulfonate): Preparation and protein interaction10.1002/mabi.200600143 ↗
27. in-situ-ATR-FTIR analysis on the uptake and release of streptomycin from polyelectrolyte complex layers
28. Deposition from dopamine solutions at Ge substrates: An in situ ATR-FTIR study10.1021/la202908b ↗
29. pH dependence and protein selectivity of poly(ethyleneimine)/poly(acrylic acid) multilayers studied by in-situ ATR-FTIR spectroscopy10.1021/bm050631r ↗
30. Temperature-sensitive swelling of poly(N-isopropylacrylamide) brushes with low molecular weight and grafting density10.1021/la204230a ↗
31. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs10.1016/0168-3659(87)90034-4 ↗